News Channel Asia: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on News Channel Asia.

Press releases published on July 1, 2026

Jul. 1, 2026

Data Center Infrastructure Market Expected to Reach US$ 752.12 Billion by 2034

Indeterminate GlobeNewswire

Jul. 1, 2026

Cold Chain Market Set to Reach USD 455.0 Billion by 2031 as Demand for Temperature-Controlled Logistics Accelerates

Indeterminate GlobeNewswire

Jul. 1, 2026

Decent Holding Inc. Expands Community Healthcare Network to Over 480 Operational Centers, Advancing Its Vision to Build China's AI-Enabled Healthy Aging Platform

Indeterminate GlobeNewswire

Jul. 1, 2026

ORYZON Raises €12 Million and Signs a Financing Agreement with COFIDES to Strengthen its Balance Sheet and Accelerate its Clinical Programs

Indeterminate GlobeNewswire

Jul. 1, 2026

MMA.INC’s BJJLink Surpasses 17,000 Monthly Active Users, Demonstrating Strong Community Platform Traction

Indeterminate GlobeNewswire

Jul. 1, 2026

Sana Biotechnology Announces Symposium Presentation at the European Association for the Study of Diabetes (EASD) Annual Meeting 2026

Indeterminate GlobeNewswire

Jul. 1, 2026

Creative Medical Technology Holdings Issues Mid-Year Update

Indeterminate GlobeNewswire

Jul. 1, 2026

MathCo Expands Databricks Center of Excellence to Help Retail and CPG Enterprises Operationalize Agentic AI

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba has received marketing authorization in France for its biofungicide AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba obtient l’autorisation de mise sur le marché en France pour son biofongicide AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba verkrijgt in Frankrijk een vergunning voor het in de handel brengen van zijn biofungicide AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba obtém autorização de colocação no mercado em França para o seu biofungicida AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba obtiene la autorización de comercialización en Francia para su biofungicida AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

Amoéba ottiene l’autorizzazione all'immissione in commercio in Francia per il suo biofungicida AXPERA

Indeterminate GlobeNewswire

Jul. 1, 2026

SERB Pharmaceuticals Completes Acquisition of European and MENA Rights to Idefirix® (imlifidase) from Hansa Biopharma

Indeterminate GlobeNewswire

Jul. 1, 2026

Borescope Market Trends and Growth, Reaching USD 1,616 Million by 2035, CAGR 5.9%

Indeterminate EIN Presswire

Jul. 1, 2026

Action Camera Market Trends Highlight a Promising 10.60% CAGR Outlook

Indeterminate EIN Presswire

Jul. 1, 2026

NETCLASS TECHNOLOGY INC Announces 1 for 50 Share Consolidation

Indeterminate GlobeNewswire

Jul. 1, 2026

IperionX Awarded Up to US$6.6M by OSW-SWIB to Scale U.S. Titanium Plate for Defense Applications

Indeterminate GlobeNewswire

Jul. 1, 2026

Apple’s Across-the-Board Price Increases Add Uncertainty to Consumer Demand; Global Notebook Shipments Forecast to Decline 13.6% in 2026, Says TrendForce

Indeterminate GlobeNewswire